{"title":"Lipid A modification-induced colistin-resistant <i>Klebsiella variicola</i> from healthy adults.","authors":"Sun Ju Kim, Jeongwoo Jo, Kwan Soo Ko","doi":"10.1099/jmm.0.001680","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background.</b> <i>Klebsiella variicola</i> was once recognised as a benign plant-endosymbiont but recent case reports suggest that it is a newly emerging Gram-negative pathogen related to opportunistic infection of multiple sites in humans.<b>Methods.</b> Antimicrobial susceptibility testing was performed using broth microdilution method. To identify colistin resistance mechanisms, <i>phoPQ</i>, <i>pmrAB</i>, and <i>mgrB</i> were sequenced and their mRNA expression was analysed using quantitative real-time PCR. In addition, we tried to detect <i>crrAB</i> and <i>mcr</i>. The lipid A moieties of colistin-susceptible and -resistant isolates were analysed using MALDI-TOF.<b>Results.</b> Among the two <i>K. variicola</i> isolates, one is colistin-resistant, and another is colistin-susceptible. The colistin-resistant <i>K. variicola</i> isolate showed no mutations in <i>phoPQ, pmrAB</i>, and <i>mgrB</i>, and <i>crrAB</i> and <i>mcr</i> were not identified. However, its <i>phoQ</i> and <i>pbgP</i> expression was significantly higher and amino-arabinosylated lipid A with hexa-acylated species in lipopolysaccharide was identified.<b>Conclusions.</b> We found that colistin resistance in <i>K. variicola</i> was mediated by the modification of lipid A. Although the isolate was obtained from faecal samples of healthy adults, colistin-resistant <i>K. variicola</i> challenges public health as an opportunistic pathogen.</p>","PeriodicalId":16343,"journal":{"name":"Journal of medical microbiology","volume":"72 6","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1099/jmm.0.001680","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background.Klebsiella variicola was once recognised as a benign plant-endosymbiont but recent case reports suggest that it is a newly emerging Gram-negative pathogen related to opportunistic infection of multiple sites in humans.Methods. Antimicrobial susceptibility testing was performed using broth microdilution method. To identify colistin resistance mechanisms, phoPQ, pmrAB, and mgrB were sequenced and their mRNA expression was analysed using quantitative real-time PCR. In addition, we tried to detect crrAB and mcr. The lipid A moieties of colistin-susceptible and -resistant isolates were analysed using MALDI-TOF.Results. Among the two K. variicola isolates, one is colistin-resistant, and another is colistin-susceptible. The colistin-resistant K. variicola isolate showed no mutations in phoPQ, pmrAB, and mgrB, and crrAB and mcr were not identified. However, its phoQ and pbgP expression was significantly higher and amino-arabinosylated lipid A with hexa-acylated species in lipopolysaccharide was identified.Conclusions. We found that colistin resistance in K. variicola was mediated by the modification of lipid A. Although the isolate was obtained from faecal samples of healthy adults, colistin-resistant K. variicola challenges public health as an opportunistic pathogen.
期刊介绍:
Journal of Medical Microbiology provides comprehensive coverage of medical, dental and veterinary microbiology, and infectious diseases. We welcome everything from laboratory research to clinical trials, including bacteriology, virology, mycology and parasitology. We publish articles under the following subject categories: Antimicrobial resistance; Clinical microbiology; Disease, diagnosis and diagnostics; Medical mycology; Molecular and microbial epidemiology; Microbiome and microbial ecology in health; One Health; Pathogenesis, virulence and host response; Prevention, therapy and therapeutics